Why the study?
Does quinidine administration alter the pharmacokinetics of digoxin in cardiac patients on long-term digoxin treatment?
Does quinidine administration alter the pharmacokinetics of digoxin in cardiac patients on long-term digoxin treatment?
Quinidine significantly alters digoxin kinetics by decreasing its renal clearance and increasing plasma concentrations, highlighting a clinically important drug-drug interaction.
Answers are grounded in this paper and cite their sources.
May warrant digoxin level monitoring with quinidine co-use; leaves open need for randomized confirmation of dosing guidance.
The pharmacokinetics of digoxin was studied in 11 subjects before and during quinidine treatment. Renal clearances of digoxin and creatinine were calculated from plasma concentrations and urinary excretions of digoxin and creatinine in subjects on long-term digoxin treatment. The investigations were repeated in the same subjects during administration of quinidine. Renal clearance of digoxin decreased, while plasma concentration of digoxin and renal excretion of digoxin increased in the presence of quididine, indicating substantial changes of digoxin kinetics, induced by quinidine. The reduction in renal clearance of digoxin may be due to a specific inhibition of tubular secretion of digoxin. The considerable rise of the plasma digoxin level and the increased excretion of digoxin support the assumption of a major extrarenal mechanism of interaction.
No takes yet. Share an insight, caveat, or question.
Pedersen et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: